消化器外科学レビュー 2010

出版社: 総合医学社
著者:
発行日: 2010-04-06
分野: 臨床医学:外科  >  消化器外科学
ISBN: 9784883783991
電子書籍版: 2010-04-06 (第1版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

10,450 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

10,450 円(税込)

商品紹介

2010年度版の本書は、2008年9月から2009年8月の1年間に発表された消化器外科学の最新の主要文献を網羅している。

目次

  • 消化器外科学レビュー 2010

    ―目次―

    I章
    1 食道・胃疾患
     1.食道癌
     2.胃食道逆流症と食道アカラシア
     3.胃  癌
     4.胃・十二指腸潰瘍,H.p
     5.食道・胃術後障害
     6.肥満外科治療  
    2 腸疾患
     1.結腸癌
     2.直腸癌
     3.炎症性腸疾患
     4.大腸腺腫・腺腫症
     5.肛門疾患   
    3 肝疾患
     1.肝細胞癌
     2.肝内胆管癌
     3.転移性肝癌
     4.その他の肝腫瘍
     5.肝移植
    4 門脈・脾
     1.門脈圧亢進症・脾機能亢進症
    5 胆道疾患
     1.胆管癌・乳頭部癌
     2.胆嚢癌
     3.胆石症・胆嚢炎と胆管炎
    6 膵疾患
     1.急性膵炎・慢性膵炎
     2.膵  癌
     3.膵管内乳頭腫瘍・嚢胞性膵腫瘍
     4.その他の膵腫瘍(膵島腫瘍,SPT,転移性膵腫瘍など)
    7 TOPICS
     1.腹部外傷
     2.NOTES
     3.Navigation Surgery
     4.GIST

    II 章
     1.癌の転移機構
     2.癌の遺伝子診断・治療
     3.抗癌剤【消化管】
     4.抗癌剤【肝胆膵】
     5.外科侵襲と生体反応
     6.感染症
     7.免  疫
     8.消化管の画像診断
     9.肝胆膵の画像診断

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I章

P.4 掲載の参考文献
1) Kuraoka K, Hoshino E, Tsuchida T et al:Early esophageal cancer can be detected by screening endoscopy assisted with narrow-band imaging(NBI). Hepatogastroenterology 56(89):63-66, 2009
4) Cotruta B, Gheorghe C, Bancila I:Magnifying endoscopy with narrow-band imaging or confocal laser endomicroscopy for in vivo rapid diagnostic of Barrett's esophagus. JGastrointestin Liver Dis 18(2):258-259, 2009
P.5 掲載の参考文献
11) Shuto K, Saito H, Ohira G et al:Diffusion-weighted MR imaging for postoperative nodal recurrence of esophageal squamous cell cancer in comparison with FDG-PET. Gan to Kagaku Ryoho 36(12):2468-2470, 2009
14) 大木岳志:ティッシュエンジニアリング治療 5 食道の再生治療. 治療学 43(6):641-645, 2009
P.6 掲載の参考文献
P.7 掲載の参考文献
P.8 掲載の参考文献
32) 幕内博康:最新の規約・ガイドライン情報食道癌診断・治療ガイドラインを考察する. 医学のあゆみ 230(10):949-954, 2009
33) 岡住慎一, 首藤潔彦, 間宮俊太 他:ガイドラインに沿った進行食道癌治療のための診断と問題点. 消化器外科 31(11):1593-1603, 2008
P.10 掲載の参考文献
P.11 掲載の参考文献
P.12 掲載の参考文献
P.13 掲載の参考文献
P.14 掲載の参考文献
P.15 掲載の参考文献
P.16 掲載の参考文献
P.17 掲載の参考文献
P.18 掲載の参考文献
P.19 掲載の参考文献
P.20 掲載の参考文献
P.21 掲載の参考文献
P.22 掲載の参考文献
P.23 掲載の参考文献
P.24 掲載の参考文献
1) Haruma K, Kamada T, Manabe N et al:Are proton pump inhibitors really superior to famotidine in Japanese ulcer patients? Hepatogastroenterology 56:1059-1063, 2009
2) 三木雅治, 足立経一, 森田照美 他:プロトンポンプ阻害剤(PPI)内服時間の酸分泌抑制効果に与える影響についての検討. 潰瘍 35:20-24, 2008
P.25 掲載の参考文献
P.26 掲載の参考文献
P.27 掲載の参考文献
P.29 掲載の参考文献
P.30 掲載の参考文献
P.31 掲載の参考文献
P.32 掲載の参考文献
P.33 掲載の参考文献
P.34 掲載の参考文献
P.35 掲載の参考文献
P.36 掲載の参考文献
P.37 掲載の参考文献
P.38 掲載の参考文献
P.39 掲載の参考文献
P.41 掲載の参考文献
P.42 掲載の参考文献
P.43 掲載の参考文献
P.44 掲載の参考文献
P.45 掲載の参考文献
P.46 掲載の参考文献
P.48 掲載の参考文献
P.49 掲載の参考文献
P.50 掲載の参考文献
P.51 掲載の参考文献
P.52 掲載の参考文献
P.53 掲載の参考文献
P.54 掲載の参考文献
P.55 掲載の参考文献
P.57 掲載の参考文献
2) 池内浩基, 内野 基, 中村光宏 他:潰瘍性大腸炎に対する最適な外科治療とは?-全大腸切除術:1期手術か 2期・3期手術か 1期手術の立場から. 臨外 64(5):581-586, 2009
P.58 掲載の参考文献
3) 杉田 昭, 小金井一隆, 木村英明 他:消化管再建術の現状と将来-最良の再建術は何か-. 大腸全摘後再建術. 日外会誌 109(5):269-273, 2008
P.59 掲載の参考文献
P.60 掲載の参考文献
P.61 掲載の参考文献
14) 東大 二郎, 二見 喜太郎, 永川 祐二 他:Crohn病における縫合不全の予防と対策. 日本大腸肛門病会誌 62:818-822, 2009
P.62 掲載の参考文献
P.63 掲載の参考文献
P.64 掲載の参考文献
P.65 掲載の参考文献
P.66 掲載の参考文献
P.67 掲載の参考文献
P.68 掲載の参考文献
P.69 掲載の参考文献
P.70 掲載の参考文献
3) 徳永行彦, 佐々木宏和, 斎藤 徹:結紮切除術と比較した痔核低侵襲性治療(ALTA, PPH)の検討. 日臨外会誌 70(2):354-357, 2009
4) 渡辺賢治, 渡辺元治, 増田英樹:内痔核患者における肛門管最大肛門静止圧の検討. 日本大腸肛門病会誌 62:160-164, 2009
P.71 掲載の参考文献
P.72 掲載の参考文献
P.73 掲載の参考文献
P.75 掲載の参考文献
P.76 掲載の参考文献
P.77 掲載の参考文献
P.78 掲載の参考文献
P.79 掲載の参考文献
21) Li M, Lu C, Cheng J et al:Combination therapy with transarterial chemoembolization and interferon-α compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma. J Hepatol Gastroenterol 24:1437-1444, 2009
23) Faivre S, Raymond E, Boucher E et al:Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma:an open-label, multicentre, phase II study. Lancet Oncol 10:794-800, 2009
24) Hiraoka A, Horiike N, Yamashita Y et al:Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3cm, along with report of complications. Hepatogastroenterology 55:2171-2174, 2008
P.80 掲載の参考文献
P.81 掲載の参考文献
P.82 掲載の参考文献
P.83 掲載の参考文献
P.84 掲載の参考文献
P.85 掲載の参考文献
P.86 掲載の参考文献
P.87 掲載の参考文献
P.88 掲載の参考文献
P.89 掲載の参考文献
P.90 掲載の参考文献
P.91 掲載の参考文献
P.92 掲載の参考文献
1) 日本肝癌研究会 編:原発性肝癌取扱い規約, 第5版. 金原出版, 2008
2) 日本肝癌研究会 編:第18回全国原発性肝癌追跡調査報告(2004~2005). 日本肝癌研究会, 2009
P.93 掲載の参考文献
3) 高木 均, 佐藤 賢, 市川 武 他:混合型肝癌10例の臨床病理学的検討. Liver Cancer 14:190-200, 2008
4) Du Wenlin, 森 泰昌, 真杉洋平 他:原発性肝癌の分類と病理学的特徴-混合型肝癌(肝細胞癌と肝内胆管癌の混合型)-. 日本臨牀 67:71-74, 2009
6) 蒲池浩文, 田原宗徳, 神山俊哉 他:原発性肝癌の分類と病理学的特徴-胆管嚢胞腺癌と胆管嚢胞腺腫の現状-. 日本臨牀 67:66-70, 2009
7) Lee JH, Lee KG, Park HK et al:Biliary cystadenoma and cystadenocarcinoma of the liver:10 cases of a single center experience. Hepato-Gastroenterlogy 56:844-849, 2009
8) 松永正訓, 佐々木文章, 大平睦郎 他:肝芽腫の集学的治療における外科療法の役割日本小児肝癌スタディグループからのJPLT-2 中間報告. 小児がん 41:205-210, 2004
P.94 掲載の参考文献
P.95 掲載の参考文献
P.96 掲載の参考文献
P.97 掲載の参考文献
P.98 掲載の参考文献
P.99 掲載の参考文献
P.100 掲載の参考文献
P.101 掲載の参考文献
P.102 掲載の参考文献
P.103 掲載の参考文献
P.104 掲載の参考文献
P.105 掲載の参考文献
P.106 掲載の参考文献
11) Ahmad I, Khan AA, Alam A et al:Propranolol, isosorbide mononitrate and endoscopic band ligation-alone or in varying combinations for the prevention of esophageal variceal rebleeding. J Coll Physicians Surg Pak 19(5):283-286, 2009
P.107 掲載の参考文献
P.108 掲載の参考文献
P.109 掲載の参考文献
P.111 掲載の参考文献
1) 近藤 哲:胆道癌診療ガイドラインをめぐって. "Annual Review 消化器 2009" 林 紀夫 他 編. 中外医学社, pp258-263, 2009
P.112 掲載の参考文献
P.113 掲載の参考文献
P.114 掲載の参考文献
P.115 掲載の参考文献
P.116 掲載の参考文献
P.117 掲載の参考文献
P.118 掲載の参考文献
P.119 掲載の参考文献
P.120 掲載の参考文献
P.121 掲載の参考文献
P.122 掲載の参考文献
25) Nanashima A, Nagasaki T, Sumida Y et al:An experience of hepatopancreatoduodenectomy in patients with hepatobiliary malignancies. Hepatogastroenterology 55:1691-1694, 2008
P.123 掲載の参考文献
P.124 掲載の参考文献
1) Chang TC, Lin MT, Wu MH et al:Evaluation of early versus delayed laparoscopic cholecystectomy in the treatment of acute cholecystitis. Hepatogastroenterol 56:26-28, 2009
P.125 掲載の参考文献
P.126 掲載の参考文献
P.127 掲載の参考文献
13) Ponsky TA:Single port laparoscopic cholecystectomy in adults and children:tools and techniques. J Am Coll Surg 2009;doi 10.1016/j. jamcollsurg. 2009.07.025
14) Roberts KE, Solomon D, Duffy AJ et al:Single-incision laparoscopic cholecystectomy:a surgeon's initial experience with 56 consecutive cases and a review of the literature. J Gastrointest Surg 2009;doi 10.1007/s11605-009-1116-z
P.128 掲載の参考文献
P.129 掲載の参考文献
P.130 掲載の参考文献
P.132 掲載の参考文献
P.133 掲載の参考文献
P.134 掲載の参考文献
12) Pezzilli R:Antibiotic prophylaxis in severe acute pancreatitis:do we need more meta-analytic studies? JOP 10:223-224, 2009
13) De Waele JJ:A role for prophylactic antibiotics in necrotizing pancreas-titis? Why we may never know the answer…. Critical Care 12:195, 2008
16) Uy MC, Daez ML, Sy PP et al:Early ERCP in acute gallstone pancreatitis without cholangitis:a meta-analysis. JOP 18;10:299-305, 2009
P.135 掲載の参考文献
P.136 掲載の参考文献
P.137 掲載の参考文献
31) Sakata N, Egawa S, Motoi F et al:How much of the pancreatic head should we resect in Frey's procedure? Surg Today 39:120-127, 2009
32) Deviere J, Bell RH Jr, Beger HG et al:Treatment of chronic pancreatitis with endotherapy or surgery:critical review of randomized control trials. J Gastrointest Surg 12:640-644, 2008
P.138 掲載の参考文献
P.139 掲載の参考文献
P.140 掲載の参考文献
P.141 掲載の参考文献
P.142 掲載の参考文献
P.143 掲載の参考文献
P.144 掲載の参考文献
P.145 掲載の参考文献
5) 多田 稔, 八島陽子, 八木岡 浩 他:IPMN 国際診療ガイドラインにより層別化した膵嚢胞性病変の経過観察による膵癌発生. 消化器科 46:350-351, 2008
6) 尾花貴志, 藤田直孝, 野田 裕 他:壁在結節からみた分枝型 IPMN の治療指針. 胆と膵 30:251-258, 2009
7) 菅野 敦, 佐藤賢一, 下瀬川 徹:組織学的悪性度と予後を反映させるための分枝型 IPMN の治療方針. 消化器科 46:328-334, 2008
8) 羽鳥 隆, 藤田 泉, 君島 映 他:主膵管径からみた IPMN の治療方針. 胆と膵 30:239-243, 2009
9) 奈良 聡, 島田和明, 阪本良弘 他:IPMCにおける「微小浸潤」の意義. 胆と膵 30:233-238, 2009
10) 米澤 傑, 東 美智代, 山 田 宗茂 他:IPMN におけるムチン発現と悪性度 ムチン発現を加味した IPMN の亜分類と国際診療ガイドラインとの関連性. 胆と膵 30:221-231, 2009
P.146 掲載の参考文献
18) Kylanpaa L, Hagstrom J, Lepisto A et al:Syndecan-1 and tenascin expression in cystic tumors of the pancreas. JOP 10(4):378-382, 2009
20) Sreenarasimhaiah J, Lara LF, Jazrawi SF et al:A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts. JOP 10(2):163-168, 2009
22) Shirai Y, Sogawa K, Yamaguchi T et al:Protein profiling in pancreatic juice for detection of intraductal papillary mucinous neoplasm of the pancreas. Hepatogastroenterology 55(86-87):1824-1829, 2008
25) Hong SP, Lee EK, Park JY et al:Cripto-1 overexpression is involved in the tumorigenesis of gastric-type and pancreatobiliary-type intraductal papillary mucinous neoplasms of the pancreas. Oncol Rep 21(1):19-24, 2009
P.147 掲載の参考文献
P.148 掲載の参考文献
36) Silverman JF, Zhu B, Liu Y et al:Distinctive immunohistochemical profile of mucinous cystic neoplasms of pancreas, ovary and lung. Histol Histopathol 24(1):77-82, 2009
37) Obayashi K, Ohwada S, Sunose Y et al:Remarkable effect of gemcitabine-oxaliplatin(GEMOX)therapy in a patient with advanced metastatic mucinous cystic neoplasm of the pancreas. Gan To Kagaku Ryoho 35(11):1915-1917, 2008
38) Shimada K, Iwase K, Aono T et al:A case of advanced mucinous cystadenocarcinoma of the pancreas with peritoneal dissemination responding to gemcitabine. Gan To Kagaku Ryoho 36(6):995-998, 2009
P.150 掲載の参考文献
P.151 掲載の参考文献
P.152 掲載の参考文献
13) Machado NO, Chopra P:Pancreatic metastasis from renal carcinoma managed by Whipple resection. A case report and literature review of metastatic pattern, surgical management and outcome. JOP 6:413-418, 2009
14) 三重野浩朗, 木下 平, 小西 大 他:3回の肺転移切除を経て, 原発巣切除6年後に膵転移を切除した直腸がんの1例. 日臨外会誌 70:163-169, 2009
P.153 掲載の参考文献
1) 日本外傷学会外傷研修コース開発委員会編:外傷初期診療ガイドライン JATEC(TM)改訂第3版. へるす出版, 2008
P.154 掲載の参考文献
P.155 掲載の参考文献
P.156 掲載の参考文献
P.157 掲載の参考文献
P.158 掲載の参考文献
P.159 掲載の参考文献
P.160 掲載の参考文献
P.161 掲載の参考文献
P.162 掲載の参考文献
P.163 掲載の参考文献
P.164 掲載の参考文献
P.165 掲載の参考文献
P.167 掲載の参考文献
8) Chen G, Li XC, Wu GQ et al:The use of virtual reality for the functional simulation of hepatic tumors(case control study). Int J Surg 2009(in press)
10) Fujiwara M, Kodera Y, Satake H et al:Navigation for laparoscopic gastrectomy with 3-dimensional computed tomography(3D-CT). Hepatogastroenterol 55:1201-1205, 2008
P.168 掲載の参考文献
P.169 掲載の参考文献
P.170 掲載の参考文献
26) Suzuki S, Suzuki N, Hattori A et al:Telecontrol function of an endoscopic surgical robot with two hands for tele-NOTES surgery. Stud Health Technol Inform 132:511-513, 2008
P.171 掲載の参考文献
P.172 掲載の参考文献
P.173 掲載の参考文献
P.174 掲載の参考文献
P.175 掲載の参考文献

II章

P.179 掲載の参考文献
P.180 掲載の参考文献
P.181 掲載の参考文献
P.182 掲載の参考文献
P.183 掲載の参考文献
P.184 掲載の参考文献
P.186 掲載の参考文献
P.187 掲載の参考文献
P.188 掲載の参考文献
P.189 掲載の参考文献
P.192 掲載の参考文献
P.193 掲載の参考文献
P.194 掲載の参考文献
P.195 掲載の参考文献
P.196 掲載の参考文献
P.197 掲載の参考文献
30) 吉田 和弘, 山口 和也, 高橋孝 夫 他:Adjuvant surgery は stage IV胃癌, 大腸癌に有用か? 日本外科系連合学会誌 33:923-924, 2008
P.198 掲載の参考文献
P.200 掲載の参考文献
2) Cheng AL, Kang YK, Chen Z et al:Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma:a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 10:25-34, 2009
4) Zhu AX, Sahani DV, Duda DG et al:Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma:a phase II study. J Clin Oncol 27:3027-3035, 2009
5) Faivre S, Raymond E, Boucher E et al:Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma:an open-label, multicentre, phase II study. Lancet Oncol 10:794-800, 2009
6) Ramanathan RK, Belani CP, Singh DA et al:A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer. Cancer Chemother Pharmacol 64:777-783, 2009
P.201 掲載の参考文献
P.202 掲載の参考文献
12) Sasaki T, Isayama H, Nakai Y et al:Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer. Cancer Chemother Pharmacol 2009(Aug 26)[Epub ahead of print]
P.203 掲載の参考文献
P.204 掲載の参考文献
24) Ueno H, Kosuge T, Matsuyama Y et al:A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer:Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer. Br J Cancer 101:908-915, 2009
P.205 掲載の参考文献
P.206 掲載の参考文献
4) Dellinger RP, Levy MM, Carlet JM et al:Surviving Sepsis Campaign:international guidelines for management of severe sepsis and septic shock:2008. Crit Care Med 36(1):296-327, 2008
P.207 掲載の参考文献
P.208 掲載の参考文献
P.209 掲載の参考文献
P.210 掲載の参考文献
P.211 掲載の参考文献
P.212 掲載の参考文献
P.213 掲載の参考文献
P.214 掲載の参考文献
P.215 掲載の参考文献
P.216 掲載の参考文献
P.217 掲載の参考文献
P.218 掲載の参考文献
9) Paavonen J, Naud P, Salmeron J et al:HPV PATRICIA Study Group, Greenacre M:Efficacy of human papillomavirus(HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types(PATRICIA):final analysis of a double-blind, randomised study in young women. Lancet 374(9686):301-314, 2009〔Epub 2009 Jul 6〕
10) Munoz N, Manalastas R Jr, Pitisuttithum P et al:Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus(types 6, 11, 16, 18)recombinant vaccine in women aged 24-45 years:a randomised, double-blind trial. Lancet 373(9679):1949-1957, 2009〔Epub 2009 Jun 1〕
11) Malfertheiner P, Schultze V, Rosenkranz B et al:Safety and immunogenicity of an intramuscular Helicobacter pylori vaccine in noninfected volunteers:a phase I study. Gastroenterology 135(3):787-795, 2008〔Epub 2008 May 28〕
13) Hattori T, Mine T, Komatsu N et al:Immunological evaluation of personalized peptide vaccination in combination with UFT and UZEL for metastatic colorectal carcinoma patients. Cancer Immunol Immunother 58(11):1843-1852, 2009〔Epub 2009 Apr 26〕
14) Kono K, Mizukami Y, Daigo Y et al:Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer. Cancer Sci 100(8):1502-1509, 2009〔Epub 2009 May 14〕
P.219 掲載の参考文献
16) Depontieu FR, Qian J, Zarling AL et al:Identification of tumor-associated, MHC class II-restricted phosphopeptides as targets for immunotherapy. Proc Natl Acad Sci USA 106(29):12073-12078, 2009〔Epub 2009 Jul 6〕
17) Assudani D, Cho HI, DeVito N et al:In vivo expansion, persistence, and function of peptide vaccine-induced CD8 T cells occur independently of CD4 T cells. Cancer Res 68(23):9892-9899, 2008
18) Sorensen MR, Holst PJ, Pircher H et al:Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+)T-cell-independent CD8(+)T-cell-mediated tumor control. Eur J Immunol 39(10):2725-2736, 2009
19) Xie Y, Bai O, Yuan J et al:Tumor apoptotic bodies inhibit CTL responses and antitumor immunity via membrane-bound transforming growth factor-beta1 inducing CD8+ T-cell anergy and CD4+ Tr1 cell responses. Cancer Res 69(19):7756-7766, 2009〔Epub 2009 Sep 29〕
20) Petrausch U, Jensen SM, Twitty C et al:Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity. J Immunol 183(6):3682-3689, 2009〔Epub 2009 Aug 19〕
21) Sharma MD, Hou DY, Liu Y et al:Indoleamine 2, 3-dioxygenase controls conversion of Foxp3+ Tregs to TH17-like cells in tumor-draining lymph nodes. Blood 113(24):6102-6111, 2009〔Epub 2009 Apr 14〕
22) Kitamura N, Murata S, Ueki T et al:OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity. Int J Cancer 125(3):630-638, 2009
P.220 掲載の参考文献
23) Brandmaier AG, Leitner WW, Ha SP et al:High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs)and mediate tumor destruction. J Immunother 32(7):677-688, 2009
24) Todaro M, D'Asaro M, Caccamo N et al:Efficient killing of human colon cancer stem cells by gammadelta T lymphocytes. J Immunol 182(11):7287-7296, 2009
25) Brandes M, Willimann K, Bioley G et al:Cross-presenting human gammadelta T cells induce robust CD8+ alphabeta T cell responses. Proc Natl Acad Sci USA 106(7):2307-2312, 2009〔Epub 2009 Jan 26〕
26) Larmonier N, Fraszczak J, Lakomy D et al:Killer dendritic cells and their potential for cancer immunotherapy. Cancer Immunol Immunother 59(1):1-11, 2010〔Epub 2009 Jul 18〕
P.221 掲載の参考文献
1) Nakamoto Y, Togashi K, Kaneta T et al:Clinical value of whole-body FDG-PET for recurrent gastric cancer:a multicenter study. Jpn J Clin Oncol 39:297-302, 2009
2) Park MJ, Lee WJ, Lim HK et al:Detecting recurrence of gastric cancer:the value of FDG PET/CT. Abdom Imaging 34:441-447, 2009
3) Sun L, Su XH, Guan YS et al:Clinical role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in post-operative follow up of gastric cancer:initial results. World J Gastroenterol 14:4627-4632, 2008
P.222 掲載の参考文献
4) Ahmadi A, Li Q, Muller K, Collins D et al:Diagnostic value of noninvasive combined fluorine-18 labeled fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography enterography in active Crohn's disease. Inflamm Bowel Dis 2009(Nov 2)[Epub ahead of print]
6) Levin B, Lieberman DA, McFarland B et al:American Cancer Society Colorectal Cancer Advisory Group;US Multi-Society Task Force;American College of Radiology Colon Cancer Committee Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008:a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 58:130-160, 2008
8) Graser A, Stieber P, Nagel D et al:Comparison of CT Colonography, colonoscopy, sigmoidoscopy, and fecal occult blood tests for the detection of advanced adenoma in an average risk population. Gut 58:241-248, 2009
9) Utano K, Endo K, Togashi K et al:Preoperative T staging of colorectal cancer by CT colonography. Dis Colon Rectum 51:875-881, 2008
10) Nagata K, Okawa T, Honma A et al:Full-laxative versus minimum-laxative fecal-tagging CT colonography using 64- detector row CT:prospective blinded comparison of diagnostic performance, tagging quality, and patient acceptance. Acad Radiol 16:780-789, 2009
11) 斎藤 博, 町井涼子, 青木綾子:大腸がんスクリーニングの現状と課題. 医学のあゆみ 230(10):935-940, 2009
P.223 掲載の参考文献
12) 吉田広行, 永田浩一:CT コロノグラフィ(大腸 3D-CT)による大腸がんスクリーニングの現状と展望. Innervision 24(12):86-87, 2009
13) Taylor SA, Iinuma G, Saito Y et al:CT colonography:computer-aided detection of morphologically flat T1 colonic carcinoma. Eur Radiol 18:1666-1673, 2008
14) Zijta FM, Bipat S, Stoker J:Magnetic resonance(MR)colonography in the detection of colorectallesions:a systematic review of prospective studies. Eur Radiol 2009(Nov 21)[Epub ahead of print]
15) Poeppel TD, Krause BJ, Heusner TA et al:PET/CT for the staging and follow-up of patients with malignancies. Eur J Radiol 70:382-392, 2009
P.224 掲載の参考文献
16) Kaltenbach T, Sano Y, Frienland S et al:American Gastroenterological Association(AGA)Institiute Technology Assessment on Image-Enhanced Endoscopy. Gastroenterology 134:327-340, 2008
17) Tajiri H, Niwa H:Proposal for a consensus terminology in endoscopy:how should different endoscopic imaging techniques be grouped and defined? Endoscopy 40:775-778, 2008
18) Rex DK, Helbig CC:High yields of small and flat adenomas with high-definition colonoscopes using either white light or narrow band imaging. Gastroenterol 133:42-47, 2007
19) Adler A, Pohl H, Papanikolaou IS et al:A prospective randomized study on narrow-band imaging versus conventional colonoscopy for adenoma detection:dose narrow-band imaging induce a learning effect? Gut 57:59-64, 2008
20) East JE, Suzuki N, Stavrinidis M et al:Narrow band imaging for colonoscopic surbeillance in hereditary non-polyposis colorectal cancer. Gut 57:280-286, 2008
21) Rastogi A, Bansal A, Wani S et al:Narrow-band imaging colonoscopy-a pilot feasibility study for the detection of polyps and correlation of surface patterns with polyp histologic diagnosis. Gastrointest Endosc 43:45-50, 2008
22) Inoue T, Murano M, Murano N et al:Comparative study of conventional colonoscopy and pan-colonic narrow-band imaging system in the detection of neoplastic colonic polyps:a randomized, comtrolled trial. J Gstroenterol 43:43-50, 2008
23) Uraoka T, Saito Y, Matsuda T et al:Detectability of colorectal neoplastic lesions using a narrow-band imaging system:a pilot study. J Gastroenterol Hepatol 23:1810-1815, 2008
24) Sikka S, Ringold DA, Jonnalagadda S et al:Comparison of white light and narrow band high definition images in predicting colon polyp histology, using standard colonoscopes without optical magnification. Endoscopy 40:818-822, 2008
25) Sano Y, Ikematsu H, Fu KI et al:Meshed capillary vessels by use of narrow-band imaging for differential diagnosis of small colorectal polyps. Gastrointest Endosc 69:278-283, 2009
P.225 掲載の参考文献
26) Hirata M, Tanaka S, Oka S et al:Evaluation of microvessels in colorectal tumors by narrow band imaging(NBI)magnification. Gastrointest Endosc 66:945-952, 2007
28) Wada Y, Kudo S, Kashida H et al:The diagnosis of colorectal lesions with magnifying narrow band imaging system. Gastrointest Endosc 70:522-531, 2009
29) Sasajima K, Kudo S, Inoue H et al:Real-time in vivo virtual histology of colorectal lesions when using the endocytoscopy system. Gastrointestinal Endoscopy 63:1010-1017, 2006
30) 工藤進英, 池原伸直, 若村邦彦 他:大腸腫瘍性病変に対する endocytoscopy. 胃と腸43:969-977, 2008
31) Kudo S, Takemura O et al:Flat and depressed types of early colorectal cancers:From east to west. GI Endoscopy Clin N Am 18:581-593, 2008
32) Cipolletta L, Blanco MA, Rotondano G et al:Enodocytoscopy can identify dysplasia in aberrant crypt foci of the colorectum:a prospective in vivo study. Endoscopy 41:129-132, 2009
33) Kiesslich R, Burg J, Vieth M et al:Confocal laser endoscopy for diagnosing intraepithelial neoplasia and colorectal cancer in vivo. Gastroenterology 127:706-713, 2004
34) Hurlstone DP, Baraza W, Brown S et al:In vivo real-time confocal laser scanning endomicroscopic colonoscopy for the detection and characterization of colorectal neoplasia. Br J Surg 95:636-645, 2008
35) Hurlstone DP, Kiesslich R, Thomson M et al:Confocal chromoscopic endomicroscopy is superior to chromoscopy alone for the detection and characterisation of intraepithelial neoplasia in chronic ulcerative colitis. Gut 57:196-204, 2008
36) Zambelli A, Villanacci V, Buscarini E et al:Collagenous colitis:a case series with confocal laser microscopy and histology correlation. Endoscopy 40:606-608, 2008
P.226 掲載の参考文献
1) Hatanaka K, Kudo M, Minami Y et al:Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies:Comparison with contrast-enhanced CT. Oncology 75(suppl 1):42-47, 2008
2) Quaia E, Alaimo V, Baratella E et al:The added diagnostic value of 64-row multidetector CT combined with contrast-enhanced US in the evaluation of hepatocellular nodule vascularity:inplications in the diagnosis of malignancy in patients with liver cirrhosis. Eur Radiology 19(3):651-663, 2009
3) Miyamoto N, Hiramatsu K, Tsuchiya K et al:Sonazoid-enhanced sonography for guiding radiofrequency ablation for hepatocellular carcinoma:better tumor visualization by Kupffer-phase imaging and vascular-phase imaging after reinjection. Jpn J Radiology 27:185-193, 2009
P.227 掲載の参考文献
4) Maruyama H, Takahashi M, Ishibashi H et al:Ultrasound-guided treatments under low acoustic power contrast harmonic imaging for hepatocellular carcinomas undetected by B-mode ultrasonography. Liver Int 29(5):708-714, 2009
5) Yu Xia, Kudo M, Minami Y et al:Response evaluation of transcatheter arterial chemoembolization in hepatocellular carcinomas:The usefulness of sonazoid-enhanced harmonic sonography. Oncology 75(suppl 1):99-105, 2008
6) Sofuni A, Itoi T, Itokawa F et al:Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy. World J Gastroenterology 14(47):7183-7191, 2008
7) Luo W, Numata K, Morimoto M et al:Clinical utility of contrast-enhanced three-dimensional ultrasound imaging with Sonazoid:findings on hepatocellular carcinoma lesions. Eur J Radiol 72(3):425-431, 2009
8) Wen Luo, Numata K, Morimoto M et al:Characterization with 3D perflubutane microbubble contrast agent-enhanced US versus 3D contrast-enhanced multidetector CT. Radiology 251:287-295, 2009
9) Horwhat JD, Gerke H, Acosta RD et al:Focal or diffuse "Fullness" of the Pancreas on CT. usually benign, but EUS Plus/Minus FNA is warranted to identify malignancy. Journal of the Pancreas 10(1):37-42, 2009
10) Ohno E, Hirooka Y, Itoh A et al:Intraductal pappilary mucinous neoplasms of the pancreas:differentiation of malignant and benign tumors by endoscopic ultrasound findings of mural nodules. Ann Surg 249:628-634, 2009
P.228 掲載の参考文献
11) Itoi T, Itokawa F, Sofuni A et al:Endoscopic ultrasound-guided choledochoduodenostomy in patients with failed endoscopic reterograde cholangiopancreatography. World J Gastroenterology 14(39):6078-6082, 2008
12) Daniele M, Darlo C, Gianmaria DF et al:Detection of hepatocellular carcinoma in patients with cirrhosis:Added value of coronal reformations from isotropic voxels with 64-MDCT. Am J Roentgenol 192:180-187, 2009
14) Satoi S, Yanagimoto H, Toyokawa H et al:Pre-operative patient selection of pancreatic cancer patients by multidetector row CT. Hepato-Gastroenterology 56:529-534, 2009
15) Ishigami K, Yoshimitsu K, Irie H et al:Significance of perivascular soft tissue around the common hepatic and proximal superior mesenteric arteries arising after pancreaticoduodenectomy:evaluation with serial MDCT studies. Abdom Imaging 33:654-661, 2008
16) Ling Tan, Ya-E Zhao, Deng-Bin Wang et al:Imaging features of intraductal papillary mucinous neoplasms of the pancreas in multi-detector row computed tomography. World J Gastroenterol 28;15(32):4037-4043, 2009
17) Hirano S, Kondo S, Tanaka E et al:Role of CT in detecting malignancy during follow-up of patoents with branch-type IPMN of the pancreas. Hepato-Gastroenterology 56:515-518, 2009
18) Manak E, Merkel S, Klein P et al:Resectability of pancreatic adenocarcinoma:assessment using multidetector-row computed tomography with multiplanar reformations. Abdom Imaging 34:75-80, 2009
19) Wei-X C, Qi-G X, Wei-F Z et al:Multiple imaging techniques in the diagnosis of ampullary carcinoma. Hepatobiliary Pancreat Dis Int 7(6):649-653, 2008
20) Watadani T, Akahane M, Yoshikawa T et al:Preoperative assessment of hilar cholangiocarcinoma using multidetector-roe CT:correlation with histopathologinal findings. Radiat Med 26:402-407, 2008
P.229 掲載の参考文献
21) Chen HW, Lai Eric CH, Pan AZ et al:Preoperative assessment and staging of hilar cholangiocarcinoma with 16- multidetector computed tomography cholangiography and angiography. HepatoGastroenterology 56:578-583, 2009
22) Soo JK, Jeong ML, Jae YL et al:Analysis of enhancement pattern of flat gallbladder wall thickening on MDCT to differentiate gallbladder cancer from cholecystitis. Am J Roentgenol 191:765-771, 2008
P.230 掲載の参考文献
23) Furukawa H, Ikuma H, Yokoe AK et al:Preoperative staging of biliary carcinoma using 18F-fluorodeoxyglucose PET:prospective comparison with PET+CT, MDCT and histopathology. Eur Radiol 18:2841-2847, 2008
24) Seo S, Doi R, Machimoto T et al:Contribution of 18F-fluorodeoxyglucose positron emission tomography to the diagnosis of early pancreatic carcinoma. J Hepatobiliary Pancreat Surg 15(6):634-639, 2008
25) Suzuki H, Kuwano H, Masuda N et al:Diagnostic usefulness of FDG-PET for malignant somatostatinoma of the pancreas. Hepatogastroenterology 55:1242-1245, 2008
26) Kumono S, Uemura M, Haraikawa T et al:Efficacy of double arterial phase dynamic magnetic resonance imaging with the sensitivity encoding technique versus dynamic multidetector-row helical computed tomography for detecting hypervascular hepatocellular cercinoma. Jpn J Radiol 27:229-236, 2009
27) Myeong JK, Jin YC, Yong EC et al:Magnetic resonance imaging of hepatocellular carcinoma using contrast media. Oncology 75(suppl 1):72-82, 2008
P.231 掲載の参考文献
28) Seong HK, Seung HK, Jongmee L et al:Gadoxetic acid-enhanced MRI versus triple-phase MDCT for the preoperative detection of Hepatocellular carcinoma. Am J Roentgenol 192:1675-1681, 2009
29) Hee SP, Jeong ML, Hei KC et al:Preoperative evaluation of pancreatic cancer:Comparison of gadolinium-enhances dynamic MRI with MR cholangiopancreatography versus MDCT. Journal of MRI 30:586-595, 2009

最近チェックした商品履歴

Loading...